Issuance of Stock Acquisition Rights to Directors and Executive Officers
First written in FY2017-Q2. 4 of 6 entries say "Advanced", first in FY2018-Q1. Latest entry: FY2026.
- FY2026AchievedAnnual report
「After vesting (shares) End of previous consolidated fiscal year 184,000 Vested — Exercised 4,000 Forfeited 180,000 Outstanding —」
The 2016 stock options had no outstanding balance after 4,000 shares were exercised and 180,000 shares expired, and their exercise period had ended. - FY2019-Q1AdvancedAnnual report
「1 April 2018– 30 June 2018 (Note) Increase resulting from the exercise of share acquisition rights. 3,000 36,100,099 4 4,758 4 3,860」
The exercise of share acquisition rights increased the total number of shares issued by 3,000 shares and increased both stated capital and capital surplus by ¥4 million in the first quarter. - FY2018AdvancedAnnual report
「During the period from 1 April 2017 to 31 March 2018, the exercise of share acquisition rights increased the total number of shares issued by 46 thousand shares and increased both stated capital and capital surplus by ¥71 million.」
The exercise of stock options issued to directors and executive officers progressed throughout the fiscal year, resulting in the issuance of 46 thousand shares and an increase of ¥71 million each in stated capital and capital surplus. - FY2018-Q3AdvancedAnnual report
「Between 1 January 2018 and 28 February 2018, the exercise of share acquisition rights increased the total number of shares issued by 29 thousand shares and increased both stated capital and capital surplus by ¥45 million.」
The exercise of share acquisition rights issued to directors and executive officers resulted in the issuance of 29 thousand shares during the period preceding the filing date and an increase of ¥45 million each in stated capital and capital surplus. - FY2018-Q1AdvancedAnnual report
「Between 1 July 2017 and 31 July 2017, the exercise of share acquisition rights increased the total number of shares issued by 17 thousand shares and increased both stated capital and capital surplus by ¥25 million.」
The exercise of share acquisition rights issued to directors and executive officers resulted in the issuance of 17 thousand shares and an increase of ¥25 million each in stated capital and capital surplus. - FY2017-Q2First statedAnnual report
「Stock acquisition rights issued during the second-quarter accounting period were as follows.」
Pursuant to a resolution dated 25 July 2016, 1,040 stock acquisition rights representing 104,000 shares were issued to directors and executive officers. The exercise price was ¥2,806 per share, and the exercise period was from 1 July 2018 to 31 March 2026.